Milind M. Narurkar

608 total citations
19 papers, 514 citations indexed

About

Milind M. Narurkar is a scholar working on Pharmacology, Organic Chemistry and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Milind M. Narurkar has authored 19 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 5 papers in Organic Chemistry and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Milind M. Narurkar's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Epilepsy research and treatment (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Milind M. Narurkar is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Epilepsy research and treatment (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Milind M. Narurkar collaborates with scholars based in United States, Japan and Germany. Milind M. Narurkar's co-authors include Md. Saiful Islam, Ashim K. Mitra, Mansoor A. Khan, A. Michael Crider, Adel H. Karara, Allison Mann, Carlos Perdomo, Gregory L. Krauss, Francesco Bibbiani and Christian E. Elger and has published in prestigious journals such as Blood, The Journal of Organic Chemistry and International Journal of Pharmaceutics.

In The Last Decade

Milind M. Narurkar

19 papers receiving 490 citations

Peers

Countries citing papers authored by Milind M. Narurkar

Since Specialization

Citations

This map shows the geographic impact of Milind M. Narurkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milind M. Narurkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milind M. Narurkar more than expected).

Fields of papers citing papers by Milind M. Narurkar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milind M. Narurkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milind M. Narurkar. The network helps show where Milind M. Narurkar may publish in the future.

Co-authorship network of co-authors of Milind M. Narurkar

This figure shows the co-authorship network connecting the top 25 collaborators of Milind M. Narurkar. A scholar is included among the top collaborators of Milind M. Narurkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milind M. Narurkar. Milind M. Narurkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Investigation of the Metabolism of Rufinamide and Its Interaction with Valproate 2011 ·Drug Metabolism Letters ·Eric T. Williams, (unknown), (unknown), Y. Nancy Wong, Tsutomu Yoshimura, David Critchley, Milind M. Narurkar	21
2	Bioavailability of Three Rufinamide Oral Suspensions Compared With the Marketed 400-mg Tablet Formulation: Results From a Randomized-Sequence, Open-Label, Four-Period, Four-Sequence Crossover Study in Healthy Subjects 2011 ·Clinical Therapeutics ·David Critchley, Jagadeesh Aluri, Peter D. W. Boyd, (unknown), Milind M. Narurkar, (unknown), Francesco Bibbiani	8
3	Rufinamide from clinical trials to clinical practice in the United States and Europe 2011 ·Epileptic Disorders ·Trevor Resnick, Alexis Arzimanoglou, Lawrence W. Brown, Robert Flamini, Michael Kerr, Gerhard Kluger, Sanjeev V. Kothare, (unknown), (unknown), Milind M. Narurkar	12
4	A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures 2010 ·Epilepsy Research ·Christian E. Elger, H. Stefan, Allison Mann, Milind M. Narurkar, Yijun Sun, Carlos Perdomo	50
5	A randomized, double‐blind, placebo‐controlled, parallel‐group study of rufinamide as adjunctive therapy for refractory partial‐onset seizures 2010 ·Epilepsia ·Victor Biton, Gregory L. Krauss, (unknown), Francesco Bibbiani, Allison Mann, Carlos Perdomo, Milind M. Narurkar	47
6	Safety and Tolerability of Rufinamide in Children With Epilepsy: A Pooled Analysis of 7 Clinical Studies 2009 ·Journal of Child Neurology ·James W. Wheless, Joan A. Conry, Gregory L. Krauss, Allison Mann, (unknown), Milind M. Narurkar	38
7	Safety, Pharmacokinetics (PK), Metabolism, and Mass Balance of [14C]-AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl Tyrosine Kinase, in Healthy Subjects. 2005 ·Blood ·Mark Kagan, (unknown), Volker Fischer, Paula Savage, (unknown), Chiaki Tanaka, Horst Schran, Milind M. Narurkar, Leila Alland	21
8	Morpholinoalkyl Ester Prodrugs of Diclofenac: Synthesis,In VitroandIn VivoEvaluation 1994 ·Journal of Pharmaceutical Sciences ·(unknown), Milind M. Narurkar, A. Michael Crider, Mansoor A. Khan	51
9	Synthesis and Evaluation of Morpholinoalkyl Ester Prodrugs of Indomethacin and Naproxen 1993 ·Pharmaceutical Research ·(unknown), Milind M. Narurkar, A. Michael Crider, Mansoor A. Khan	48
10	Solubility, Stability and Ionization Behaviour of Famotidine 1993 ·Journal of Pharmacy and Pharmacology ·Md. Saiful Islam, Milind M. Narurkar	42
11	The effect of 2-hydroxypropyl-ß-cyclodextrin on the solubility, stability and dissolution rate of famotidine 1991 ·Drug Development and Industrial Pharmacy ·Md. Saiful Islam, Milind M. Narurkar	15
12	In vitro and in vivo evaluation of sustained release suspensions of ibuprofen 1991 ·International Journal of Pharmaceutics ·(unknown), Milind M. Narurkar	26
13	Effect of 2-Hydroxypropyl-β-cyclodextrin on the Ocular Absorption of Dexamethasone and Dexamethasone Acetate 1991 ·Pharmaceutical Research ·(unknown), Adel H. Karara, Milind M. Narurkar	68
14	Prodrugs of 5-Iodo-2′-Deoxyuridine for Enhanced Ocular Transport 1989 ·Pharmaceutical Research ·Milind M. Narurkar, Ashim K. Mitra	24
15	Synthesis, Physicochemical Properties, and Cytotoxicity of a Series of 5′-Ester Prodrugs of 5-Iodo-2′-deoxyuridine 1988 ·Pharmaceutical Research ·Milind M. Narurkar, Ashim K. Mitra	21
16	Improved ocular delivery of idoxuridine using the prodrug approach 1988 ·Purdue e-Pubs (Purdue University System) ·Milind M. Narurkar	1
17	Kinetics of azathioprine degradation in aqueous solution 1987 ·International Journal of Pharmaceutics ·Adinpunya Mitra, Milind M. Narurkar	9
18	Effect of mercaptan nucleophiles on the degradation of azathioprine in aqueous solution 1986 ·International Journal of Pharmaceutics ·Ashim K. Mitra, Milind M. Narurkar	7
19	Solvent effects on fluorescence properties of sodium lasalocid (ionophore X-537A) 1984 ·The Journal of Organic Chemistry ·Ashim K. Mitra, Milind M. Narurkar	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact